Literature DB >> 12393689

How I treat heparin-induced thrombocytopenia and thrombosis.

Barbara M Alving1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12393689     DOI： 10.1182/blood-2002-04-1089

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.

Authors:  Albrecht Leo; Susanne Winteroll
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 2.  Thrombocytopenias: a clinical point of view.

Authors:  Dino Veneri; Massimo Franchini; Federica Randon; Ilaria Nichele; Giovanni Pizzolo; Achille Ambrosetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

3.  Hats Off to HIT: A Case Report.

Authors:  Akhwand Shakeel Ahmad; Dhia Jaber Al-Layla; Manjula Dhinakar
Journal:  Oman Med J       Date:  2012-05

4.  The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia.

Authors:  Allyson M Pishko; Daniel S Lefler; Phyllis Gimotty; Koosha Paydary; Sara Fardin; Gowthami M Arepally; Mark Crowther; Lawrence Rice; Rolando Vega; Douglas B Cines; James P Guevara; Adam Cuker
Journal:  J Thromb Haemost       Date:  2019-08-12       Impact factor: 5.824

5.  Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.

Authors:  John R Bartholomew; Carolynn E Pietrangeli; Marcie J Hursting
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Authors:  Ming-Shen Dai; An-Tie Hsieh; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2004-04-28       Impact factor: 3.603

7.  Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban.

Authors:  Marcie J Hursting; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2008-11-19       Impact factor: 2.300

8.  Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach.

Authors:  Hikmat Abdel-Razeq; Yousef Ismael
Journal:  Ther Clin Risk Manag       Date:  2011-06-14       Impact factor: 2.423

9.  Heparin-induced thrombocytopenia: an update.

Authors:  Massimo Franchini
Journal:  Thromb J       Date:  2005-10-04

10.  Heparin-induced thrombocytopaenia (HIT)-an overview: what does the nephrologist need to know and do?

Authors:  Tina Dutt; Michael Schulz
Journal:  Clin Kidney J       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.